CYP2C19*2 variant is a predictor of poor clopidigrel response and can be base for the economically rationalized antiagregation therapy protocol in Serbian population

Rakicević, Ljiljana; Novković, Mirjana; Kušić-Tišma J.; Matić, D.; Antonijević, A.; Backović, D.; Calija, B.; Strugarević, E.; Radak, Đ.; Kovač, M.; Mitropoulou, C.; van Schaik, R.; Fragoulakis, V.; Vozikis, A.; Patrionos ,G.; Radojković, D.

Results

eNauka > Results > CYP2C19*2 variant is a predictor of poor clopidigrel response and can be base for the economically rationalized antiagregation therapy protocol in Serbian population

Title:	CYP2C19*2 variant is a predictor of poor clopidigrel response and can be base for the economically rationalized antiagregation therapy protocol in Serbian population
Authors:	Rakicević, Ljiljana ; Novković, Mirjana ; Kušić-Tišma J. ; Matić, D.; Antonijević, A.; Backović, D.; Calija, B.; Strugarević, E.; Radak, Đ.; Kovač, M.; Mitropoulou, C.; van Schaik, R.; Fragoulakis, V.; Vozikis, A.; Patrionos ,G.; Radojković, D.;
Issue Date:	2019
Publication:	6thMeeting of European Section and 7th Meeting of North American Section of the International Academy of Cardiovascular Sciences (IACS)
Type:	Conference Paper
URI:	https://enauka.gov.rs/handle/123456789/773558
URL:	http://www.physiology.org.rs/eng/htm/konf2019/6th%20Meeting%20of%20the%20IACS%202019%20( Final%20Program).pdf
Metadata source:	(Preuzeto iz ORCID-a) Novkovic, Mirjana
M-category:	Mp. category will be shown later

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.

Google Scholar^TM